Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-carnitine tartrate + creatine monohydrate is a dietary supplement combination commonly used for muscle health and performance enhancement. L-carnitine tartrate is a salt form of the amino acid derivative L-carnitine, which facilitates the transport of long-chain fatty acids into the mitochondria for beta-oxidation, thereby supporting cellular energy production and ATP synthesis. Creatine monohydrate is a stable, water-soluble compound that replenishes phosphocreatine stores in muscle cells, supporting rapid ATP regeneration during high-intensity activities. Combined, these substances have a synergistic effect, potentially enhancing muscle protein synthesis and anabolic signaling in muscle cells more than either compound alone. This combination has been shown to increase the phosphorylation of key anabolic proteins like AKT and RPS6 and to significantly increase plasma creatine and serum carnitine concentrations in human subjects, suggesting improved bioavailability and anabolic potential[1][2][3]. This combination is found in several recovery and muscle growth dietary supplements, often as a post-workout formula.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-carnitine tartrate + creatine monohydrate.